The DOI matches its Crossref record; 83 of the 84 references it cites were found in a registry or an index.
A Four-Chemokine Signature Is Associated with a T-cell–Inflamed Phenotype in Primary and Metastatic Pancreatic Cancer
Published version of a preprint
Abstract
Purpose: The molecular drivers of antitumor immunity in pancreatic ductal adenocarcinoma (PDAC) are poorly understood, posing a major obstacle for the identification of patients potentially amenable for immune-checkpoint blockade or other novel strategies. Here, we explore the association of chemokine expression with effector T-cell infiltration in PDAC. Experimental Design: Discovery cohorts comprised 113 primary resected PDAC and 107 PDAC liver metastases. Validation cohorts comprised 182 PDAC from The Cancer Genome Atlas and 92 PDACs from the Australian International Cancer Genome Consortium. We explored associations between immune cell counts by immunohistochemistry, chemokine expression, and transcriptional hallmarks of antitumor immunity by RNA sequencing (RNA-seq), and mutational burden by whole-genome sequencing. Results: Among all known human chemokines, a coregulated set of four (CCL4, CCL5, CXCL9, and CXCL10) was strongly associated with CD8+ T-cell infiltration (P < 0.001). Expression of this “4-chemokine signature” positively correlated with transcriptional metrics of T-cell activation (ZAP70, ITK, and IL2RB), cytolytic activity (GZMA and PRF1), and immunosuppression (PDL1, PD1, CTLA4, TIM3, TIGIT, LAG3, FASLG, and IDO1). Furthermore, the 4-chemokine signature marked tumors with increased T-cell activation scores (MHC I presentation, T-cell/APC costimulation) and elevated expression of innate immune sensing pathways involved in T-cell priming (STING and NLRP3 inflammasome pathways, BATF3-driven dendritic cells). Importantly, expression of this 4-chemokine signature was consistently indicative of a T-cell–inflamed phenotype across primary PDAC and PDAC liver metastases. Conclusions: A conserved 4-chemokine signature marks resectable and metastatic PDAC tumors with an active antitumor phenotype. This could have implications for the appropriate selection of PDAC patients in immunotherapy trials.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Among these, SMAD4 loss is associated with aggressive disease biology, metastatic potential, and altered tumor microenvironmental features [52].”
From Precision Targeting of KRAS-Mutant Cancers: Beyond G12C Toward G12D and Pan-RAS Therapeutic Strategies (2026) · cites this paper as [52]
Citations
Cites
Robinson, M. D., McCarthy, D. J., & Smyth, G. K. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp616 · Cited by 41,364
Siegel, R. L., Miller, K. D., & Jemal, A. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21551 · Cited by 20,160
GSVA: gene set variation analysis for microarray and RNA-Seq data
Hänzelmann, S., Castelo, R., & Guinney, J. (2013) · BMC Bioinformatics · doi:10.1186/1471-2105-14-7 · Cited by 15,440 · cited 1×
“To account for the continuous nature of TPM values, the default Gaussian distribution for the kcdf argument of the gsva function was used (36), with a minimum and maximum gene set size of 2 and 500, respectively.”
MethodThe Molecular Signatures Database Hallmark Gene Set Collection
Liberzon, A., Birger, C., Thorvaldsdóttir, H., Ghandi, M., Mesirov, J. P., & Tamayo, P. (2015) · Cell Systems · doi:10.1016/j.cels.2015.12.004 · Cited by 13,807 · cited 1×
“Gene set enrichment analysis, using the MSigDB Hallmark and C2:Canonical Pathways curated gene sets (51), revealed a pronounced enrichment in processes involved with immune regulation, T-cell signaling, cytokine signaling, and immune extravasation in the 4-chemokine samples (Fig.”
MethodThe cancer genome atlas pan-cancer analysis project
The Cancer Genome Atlas Research Network, Weinstein, J. N., Collisson, E. A., Mills, G. B., Shaw, K. R. M., Ozenberger, B. A., Ellrott, K., Shmulevich, I., Sander, C., & Stuart, J. M. (2013) · Nature Genetics · doi:10.1038/ng.2764 · Cited by 9,092
QuPath: Open source software for digital pathology image analysis
Bankhead, P., Loughrey, M. B., Fernández, J. A., Dombrowski, Y., McArt, D. G., Dunne, P. D., McQuaid, S., Gray, R. T., Murray, L. J., Coleman, H. G., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-17204-5 · Cited by 8,908 · cited 1×
“The number of CD8þTILswas normalized by tumor area (total tissue area after exclusion of non-tumor regions) in mm(2) calculated using QuPath Image analysis software (30).”
MethodSafety and activity of anti-PD-L1 antibody in patients with advanced cancer
Brahmer, J. R., Tykodi, S. S., Chow, L. Q. M., Hwu, W.-J., Topalian, S. L., Hwu, P., Drake, C. G., Camacho, L. H., Kauh, J., Odunsi, K., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200694 · Cited by 7,945
In situ click chemistry generation of cyclooxygenase-2 inhibitors
Bhardwaj, A., Kaur, J., Wuest, M., & Wuest, F. (2017) · Nature Communications · doi:10.1038/s41467-016-0009-6 · Cited by 7,448
Spencer, P. M., Cameron, J. L., & Lin, L. (2000) · Cited by 7,202
Molecular signatures database (MSigDB) 3.0
Liberzon, A., Subramanian, A., Pinchback, R., Thorvaldsdóttir, H., Tamayo, P., & Mesirov, J. P. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr260 · Cited by 7,111 · cited 2×
“Interestingly, we observed both the stimulator of interferon genes (STING) and the NLRP3 inflammasome pathway (39) upregulated in the 4-chemokine group (Fig.”
BackgroundMethod
Research works printed but not linked: 1
- Cameron, 2013, Cytokines, chemokines and their receptors [book on the Internet], Madame Curie Biosci Database
Cited by
Pancreatic cancer evolution and heterogeneity: integrating omics and clinical data
Connor, A. A., & Gallinger, S. (2022) · Nature Reviews Cancer · doi:10.1038/s41568-021-00418-1 · Cited by 369
Self-citationHoch, T., Schulz, D., Eling, N., Gómez, J. M., Levesque, M. P., & Bodenmiller, B. (2022) · Science Immunology · doi:10.1126/sciimmunol.abk1692 · Cited by 250
Shi, X., Yang, Y., Zhang, W., Wang, J., Xiao, D., Ren, H., Wang, T., Gao, F., Liu, Z., Zhou, K., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2208506119 · Cited by 131
Kirchhammer, N., Trefny, M. P., Natoli, M., Brücher, D., Smith, S. N., Werner, F., Koch, V., Schreiner, D., Bartoszek, E. M., Buchi, M., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abm9043 · Cited by 93
Schmassmann, P., Roux, J., Buck, A., Tatari, N., Hogan, S. A., Wang, J., Mantuano, N. R., Wieboldt, R., Lee, S., Snijder, B., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.adf5302 · Cited by 87
Metadata
- Authors
- Romero, J. M., Grünwald, B., Jang, G.-H., Bavi, P. P., Jhaveri, A., Masoomian, M., Fischer, S. E., Zhang, A., Denroche, R. E., Lungu, I. M., De Luca, A., Bartlett, J. M. S., Xu, J., Li, N., Dhaliwal, S., Liang, S.-B., Chadwick, D., Vyas, F., Bronsert, P., Khokha, R., McGaha, T. L., Notta, F., Ohashi, P. S., Done, S. J., O'Kane, G. M., Wilson, J. M., Knox, J. J., Connor, A., Wang, Y., Zogopoulos, G., & Gallinger, S.
- Affiliations
- Ontario Institute for Cancer Research (CA)
- University Health Network (CA)
- 5Diagnostic Development, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
- University of Freiburg (DE)
- Research Institute of the McGill University Health Centre (CA)
- 1Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
- ORCID
- Romero, Joan M.
- Grünwald, Barbara
- Jang, Gun-Ho
- Bavi, Prashant P.
- Jhaveri, Aaditeya
- Fischer, Sandra E.
- Zhang, Amy
- Denroche, Robert E.
- Lungu, Ilinca M.
- Bartlett, John M.S.
- Xu, Jing
- Li, Niandong
- Dhaliwal, Sharon
- Liang, Sheng-Ben
- Vyas, Foram
- Bronsert, Peter
- Khokha, Rama
- McGaha, Tracy L.
- Notta, Faiyaz
- Ohashi, Pamela S.
- Done, Susan J.
- O'Kane, Grainne M.
- Wilson, Julie M.
- Knox, Jennifer J.
- Connor, Ashton
- Wang, Yifan
- Zogopoulos, George
- Venue
- Clinical Cancer Research
- Published
- 2020-04-15
- Volume
- 26
- Issue
- 8
- Pages
- 1997-2010
- ISSN
- 1078-0432 (ISSN-L)
- 1557-3265
- OpenAlex
- W3002753972
- Cited by
- 146
- References
- 84
- Citations by year
- 2026: 12 · 2025: 14 · 2024: 30 · 2023: 31 · 2022: 32 · 2021: 21 · 2020: 5
- FWCI
- 8.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Canadian Friends of the Hebrew University
- Pancreatic Cancer Canada Foundation
- Lebovic Chair in Hepatobiliary
- pancreatic Surgical Oncology
- Canadian Institutes of Health Research (ALTF 116-2018)
- Alexander von Humboldt Foundation (DEU 1199182)
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
- Keywords
- pancreatic ductal adenocarcinoma, carbon tetrachloride, RANTES, CXCL9, CXCL10, CD8+ T cell infiltration, antitumor immunity, liver metastasis, immune checkpoint blockade, T cell activation, immunosuppression, STING pathway, NLRP3 inflammasome, Batf3, dendritic cells, mutational burden, immunotherapy patient selection
- MeSH terms
- RNA-Seq, Immune Checkpoint Proteins, Humans, Immunotherapy, Liver Neoplasms, Mutation, Pancreatic Neoplasms, Biomarkers, Tumor, Cohort Studies, CD8-Positive T-Lymphocytes, Chemokine CCL5, Computational Biology, Databases, Genetic, Chemokine CXCL10, Chemokine CXCL9, Chemokine CCL4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Four-Chemokine Signature Is Associated with a T-cell–Inflamed Phenotype in Primary and Metastatic Pancreatic Cancer. https://app.cochat.ai/papers/10.1158/1078-0432.ccr-19-2803
- The paper
- Romero, J. M., Grünwald, B., Jang, G.-H., Bavi, P. P., Jhaveri, A., Masoomian, M., Fischer, S. E., Zhang, A., Denroche, R. E., Lungu, I. M., De Luca, A., Bartlett, J. M. S., Xu, J., Li, N., Dhaliwal, S., Liang, S.-B., Chadwick, D., Vyas, F., Bronsert, P., . . . Gallinger, S. (2020). A Four-Chemokine Signature Is Associated with a T-cell–Inflamed Phenotype in Primary and Metastatic Pancreatic Cancer. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-19-2803
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.